Dr Reddy's Laboratories

Dr Reddy's Laboratories is a multinational pharmaceutical company headquartered in India. The company is currently relevant due to the recent expiration of patents for semaglutide, the active ingredient in popular drugs like Ozempic and Wegovy, in key markets such as India and China. This patent expiration allows for the production and sale of generic versions of these medications. India, known for its robust generic drug manufacturing capabilities, has already begun commercializing these cheaper alternatives. This development is significant as it could potentially reshape the global fight against obesity by making weight-loss treatments more accessible to millions of people. Dr Reddy's Laboratories, as a major player in the Indian pharmaceutical landscape, is positioned to be a key contributor to this shift, offering more affordable options for diabetes and weight management.